Document 6zNEzegXkeNX9v0MaG27rdYg

2965194 From: To: Cc: Subject: Date: Attachments: Dear Mr RE: Follow-up meeting proposal donderdag 13 januari 2022 09:27:02 image012.ong im 13.pni im 15.0n im 16.0n im 1.0n thank you for this opportunity . Please see below some availabilities to organize the meeting February 2%: 5.30-6.30pm February 3" : 3pm-6pm February 4th 3pm-6pm February 7: 3pm-5pm February 9th, 2pm-6pm Let me know if one of those dates can work for you, Best regards, EEE... 5.1.2e HPP Business Unit M: 5.1.2e ARKENA vm nl> De: EET Envoy : mercredi 12 janvier 2022 13:17 A: SEE 2 ema.com> Cc: SEE vm n>; ETI riv.nl> Objet : RE: Follow-up meeting proposal Dear Ms Also my best wishes for 2022. Apologies for not replying on your previous email. We would be interested to have a meeting in January or February and learn (even) more on the substitutes for PFAS polymerization aids and on decommissioning and recycling. From RIVM and I would be interested to attend. Kind regards, Centre for Safety of Substances and Products National Institute for Public Health and the Environment Antonie van Leeuwenhoeklaan 9 | 3721 MA Bilthoven PO Box 1 (postbak 1) | 3720 BA Bilthoven | The Netherlands 2965194 From: EEEke: na. com> Sent: woensdag 12 januari 2022 09:09 To: rivm.nl> Subject: RE: Follow-up meeting proposal Dear Mr , first of all my best wishes for 2022 ! I am just following-up on the below email and would like to know if you would be interested by this meeting proposal for January or February. Best regards, 5.41.28 5.1.2e HPP Business Unit M: 5.1.2 Fluoropolymers ARKE/ NA www.extremematerials-arkema.com De: Envoy : mardi 21 dcembre 2021 09:01 A: IEEEETE Civ. Cc : IEEE <JER2 rF kemI a.c> om> Objet : Follow-up meeting proposal Dear Mr. As a follow-up to the second call for evidence, we would like to extend an invitation to discuss in more detail some aspects of our submission. In particular, we would like to share some additional details regarding the substitutes for PFAS polymerization aids used in the manufacturing of Arkema PVDF, our outlook on PVDF decommissioning & recycling and our conclusions on recent data collected on PVDF biodegradation, stability and aging. We remain committed to generating other information to help support the regulatory process as needed. We have also hired a consultant to help us improve our understanding of the end of life of PVDF. Your feedback on 2965194 the study design would be very important to us. We would also be interested to know if you have identified uses for which sufficient data have not been provided during the second call for evidence and whether we can assist you through our contacts in the business community to obtain such information. Please let me know if you would be available during beginning of January to arrange a meeting. Kind regards, and wishing you a Merry Christmas, sa 5.1.2 HPP Business Unit M: 5.1.2e ARKE/ NA -- Ce courriel, pieces jointes incluses, peut contenir des informations confidentielles et/ou couvertes par le secret professionnel et/ou proprit du Groupe Arkema ou de tiers. Il ne peut tre utilis que dans le cadre de son objet. Si vous n'en tes pas le destinataire, merci d'en informer I'expditeur par retour et de supprimer ce courriel sans le lire, le copier ni le distribuer. Merci. This e-mail, attachments included, may contain information that is confidential and/or privileged and/or proprietary to the Arkema Group or third party. It may only be used for its intended purpose. If you are not the intended recipient, please advise the sender by return and delete this e-mail without reading, copying nor distributing it. Thank you. Dit bericht kan informatie bevatten die niet voor u is bestemd. Indien u niet de geadresseerde bent of dit bericht abusievelijk aan u is verzonden, wordt u verzocht dat aan de afzender te melden en het bericht te verwijderen. Het RIVM aanvaardt geen aansprakelijkheid voor schade, van welke aard ook, die verband houdt met risico's verbonden aan het elektronisch verzenden van berichten. www.rivm.nl De zorg voor morgen begint vandaag This message may contain information that is not intended for you. If you are not the addressee or if this message was sent to you by mistake, you are requested to inform the sender and delete the message. RIVM accepts no liability for damage of any kind resulting from the risks inherent in the electronic transmission of messages. www.rivm.nl/en Committed to health and sustainability Ce courriel, pieces jointes incluses, peut contenir des informations confidentielles et/ou couvertes par le secret professionnel et/ou proprit du Groupe Arkema ou de tiers. Il ne peut tre utilis que dans le cadre de son objet. Si vous n'en tes pas le destinataire, merci d'en informer I'expditeur par retour et de supprimer ce courriel sans le lire, le copier ni le distribuer. Merci. This e-mail, attachments included, may contain information that is confidential and/or privileged and/or proprietary to the Arkema Group or third party. It may only be used for its intended purpose. If you are not the intended recipient, please advise the sender by return and delete this e-mail without reading, copying nor distributing it. Thank you.